1. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic. Issue 10 (October 2021) Authors: Favara, D.M.; McAdam, K.; Cooke, A.; Bordessa-Kelly, A.; Budriunaite, I.; Bossingham, S.; Houghton, S.; Doffinger, R.; Ainsworth, N.; Corrie, P.G. Journal: Clinical oncology Issue: Volume 33:Issue 10(2021) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Issue 1 (January 2021) Authors: Earl, H.M.; Hiller, L.; Dunn, J.; Macpherson, I.; Rea, D.; Hughes-Davies, L.; McAdam, K.; Hall, P.; Mansi, J.; Wheatley, D.; Abraham, J.E.; Caldas, C.; Gasson, S.; O'Riordan, E.; Wilcox, M.; Miles, D.; Cameron, D.A.; Wardley, A. Journal: Clinical oncology Issue: Volume 33:Issue 1(2021) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Does Neo-adjuvant chemotherapy response in the primary breast tumour correlate with axillary response in proven node positive ER positive HER2 negative disease?. (October 2020) Authors: Borkar, N.; Provenzano, E.; Garreffa, E.; Benson, J.; Forouhi, P.; Hugh-Davies, L.; Wilson, C.; McAdam, K.; Russell, S.; Agrawal, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Should chemotherapy in neoadjuvant setting in node positive breast cancers be guided by biology over magnitude of tumour burden?. (October 2020) Authors: Provenzano, E.; Garreffa, E.; Wignarajah, P.; Borkar, N.; Psychogiou, V.; Newton, A.; Benson, J.; Forouhi, P.; Hughes-Davies, L.; Wilson, C.; McAdam, K.; Russell, S.; Agrawal, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce. Issue 1 (January 2021) Authors: Favara, D.M.; Cooke, A.; Doffinger, R.; McAdam, K.; Corrie, P.; Ainsworth, N.L. Journal: Clinical oncology Issue: Volume 33:Issue 1(2021) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings. (April 2023) Authors: Hall, P.; Howell, S.; Venkitaraman, R.; Thomson, A.; Raja, F.; King, J.; Michie, C.; Khan, S.; Brunt, A.M.; Gahir, D.; McAdam, K.; Cooner, J.; Kane, N. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗